Bifidobacterium breve Probiotic Powder | 200B CFU/g | GMP Certified Supplier
Bifidobacterium breve is one of the core probiotics in the human gut, belonging to the Bifidobacterium genus, and is naturally present in the intestines of healthy infants and adults. As an FDA GRAS-certified strain, it exhibits excellent acid and bile tolerance, along with clinically proven health benefits. It is widely used to improve gut microbiota balance, enhance immune function, and regulate metabolism. Our product is made from Bifidobacterium breve using a high-density cultivation fermentation process and low-temperature freeze-drying protection technology. The freeze-dried bacterial powder includes the strain, protective agent, and diluent carriers.
Key functions and benefits
High Survival Rate
Utilizes triple microencapsulation technology, with a gastric acid and bile salt tolerance of 92%.
Gut Health
Repairs the intestinal barrier, increases beneficial bacteria, and inhibits the colonization of pathogenic bacteria.
Immune Regulation
Reduces allergy risks and enhances immune defense.
Metabolic Support
Produces short-chain fatty acids and improves insulin sensitivity.
Why choose our Bifidobacterium breve strain?
Ultra-high probiotic count & excellent stability
≥2 billion CFU/gram (supported by third-party testing report).
Patent-pending microencapsulation technology, with a survival rate of >90% when stored at room temperature for 24 months.
Gastric acid and bile salt tolerance ≥85% (verified by simulated digestion experiments).
Global compliance, easy access to international markets
FDA GRAS certification | EFSA QPS approval | Registration with China's National Health Commission.
Compliant with regulatory requirements in the United States, European Union, Japan, China, and other regions.
Strict quality control, safe and reliable
GMP & ISO 22000 certified production, with COA provided for each batch.
Allergen-free (no dairy, gluten residues).
Flexible supply, supporting customization
1kg small-scale trials → Ton-scale production, meeting different needs.
OEM/ODM services (customized CFU, dosage forms, packaging).
Applications
Infant nutrition products
Infant formula milk, probiotic drops/powder: Relieve infant colic, diarrhea, and enhance immunity.
Functional foods & beverages
Probiotic yogurt/fermented dairy, probiotic chocolate/candies, probiotic drinks: Increase short-chain fatty acid production, improve gut environment, and assist in regulating blood sugar metabolism.
Dietary supplements
Probiotic capsules/tablets, women's intimate care probiotics: Improve irritable bowel syndrome (IBS) symptoms and enhance mucosal immunity (sIgA levels).
Scientific Clinical Research
Reducing the risk of necrotizing enterocolitis (NEC) in preterm infants: Enhances gut barrier function (Occludin protein expression ↑35%), with a 42% reduction in NEC incidence in the B. breve group.
Preventing infant eczema: Modulates the IgE/Th2 immune pathway, with a 41% decrease in eczema incidence in the supplementation group.
Gut health: Strengthens gut barrier: By upregulating tight junction proteins (ZO-1, Occludin) and secreting antimicrobial peptides, it inhibits E. coli colonization, leading to a 67% reduction in antibiotic-associated diarrhea incidence.
Irritable bowel syndrome (IBS): 39% improvement in IBS symptoms, and a 52% reduction in Clostridium difficile infection recurrence.
Upper respiratory infections: Salivary sIgA levels increased by 28%, with a 35% reduction in the frequency of childhood winter colds.
Technical Specifications
|
Strain Name |
Bifidobacterium breve BB-47 |
|
Viable Count |
≥2×1011 CFU/g |
|
Moisture |
≤5.0% |
|
Packing |
500g/bag, 1kg/bag, 5kg/bag or customized |
Production Process
FAQ
Hot Tags: bifidobacterium breve, China bifidobacterium breve manufacturers, suppliers, factory, lactobacillus acidophilus lactobacillus rhamnosus, lactobacillus rhamnosus and gasseri, lactobacillus acidophilus candidiase, bifidobacterium bifidum ha 132, kaleidon probiotic fast, probiotic with lactobacillus gasseri and rhamnosus
